Zobrazeno 1 - 10
of 23
pro vyhledávání: '"B. Hoogeland"'
Autor:
Armin Buschauer, Serena Cuboni, Klaus T. Wanner, Christian Devigny, Barbara Hauger, Georg Höfner, Sebastian Pomplun, Matthias Eder, Florian Holsboer, B. Hoogeland, Andrea Strasser, Felix Hausch
Publikováno v:
Journal of Medicinal Chemistry. 57:9473-9479
B(0)AT2, encoded by the SLC6A15 gene, is a transporter for neutral amino acids that has recently been implicated in mood and metabolic disorders. It is predominantly expressed in the brain, but little is otherwise known about its function. To identif
Autor:
S. Gaali, Felix Hausch, C. Kress, Christian Kozany, B. Hoogeland, Andreas Bracher, R. Gopalakrishnan
Publikováno v:
Journal of Medicinal Chemistry. 55:4114-4122
The FK506-binding proteins (FKBP) 51 and 52 are cochaperones that modulate the signal transduction of steroid hormone receptors. Both proteins have been implicated in prostate cancer. Furthermore, single nucleotide polymorphisms in the gene encoding
Autor:
Christian Devigny, Serena Cuboni, Jan M. Deussing, Felix Hausch, Katharine J Webb, Christoph P. Mauch, Francisco Perez-Balderas, Rudolf Wachtel, B. Hoogeland
Publikováno v:
Journal of the American Chemical Society. 133:8927-8933
The 41-amino acid peptide corticotropin releasing factor (CRF) is a major modulator of the mammalian stress response. Upon stressful stimuli, it binds to the corticotropin releasing factor receptor 1 (CRF(1)R), a typical member of the class-B G-prote
Autor:
Y. Wang, Christian Kozany, R. Gopalakrishnan, B. Hoogeland, Felix Hausch, Sabine Schneider, Andreas Bracher
Publikováno v:
Journal of medicinal chemistry. 55(9)
FK506-binding proteins (FKBP) 51 and 52 are cochaperones that modulate the signal transduction of steroid hormone receptors. Single nucleotide polymorphisms in the gene encoding FKBP51 have been associated with a variety of psychiatric disorders. Rap
Publikováno v:
Pharmacopsychiatry. 44
Publikováno v:
Pharmacopsychiatry. 44
Publikováno v:
Pharmacopsychiatry. 44
There are strong indications for the involvement of cyclophilin 40 in diseases caused by misregulation of steroid hormone receptors, like prostate or breast cancer. To identify novel inhibitors for this immunophilin, we developed a simplified fluores
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41ede9210ff9bd087205b400fd0b550b
https://europepmc.org/articles/PMC4007835/
https://europepmc.org/articles/PMC4007835/
Publikováno v:
Pharmacopsychiatry. 42
Autor:
Uwe Koch, Y. Wang, B. Hoogeland, R. Gopalakrishnan, Christian Kozany, Andreas Bracher, C. Kress, Anne-Katrin Fabian, Felix Hausch, Alexander Kirschner
The design of efficient ligands remains a key challenge in drug discovery. In the quest for lead-like ligands for the FK506-binding protein 51 (FKBP51), we designed two new classes of bicyclic sulfonamides to probe the contribution of conformational
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6ce218b4b2850e17135b2aa507a52ee
https://infoscience.epfl.ch/record/189077
https://infoscience.epfl.ch/record/189077